Antheia News and Activities

Acquisition, funding and merger involving Antheia.

• Antheia has just announced a $56 Million fundraising (posted on October 21 2025).

View the org chart displaying its 21 main executives

Most searched biographies at Antheia

• Christina Smolke, Chief Executive Officer and Director
• Franziska Heeg, Director
• John Nicols, Chairman of the Board

Popular executive movements at Antheia

• Chris Savile has joined the company as Vice President of Business Development and Partnerships  (posted on March 22 2026).
• Guerin Kob, who was Vice President, Supply Chain, is promoted to Senior Vice President, Supply Chain and External Manufacturing  (posted on March 22 2026).
• Eric D'esparbes has joined the company as Chief Financial Officer  (posted on October 10 2025).

Create your alert
to follow the executive moves at Antheia.

Antheia has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Antheia

• Newsroom
• Antheia expands US biosynthesis project to strengthen drug supply chains
• ASPR to invest in domestic production of ingredient for pain management, overdose reversal medications | AHA News
• Newsroom
• Newsroom
• Newsroom
• Newsletters - Antheia
• Newsroom
• Newsroom
• Newsroom
• View more press releases Close

Social media about Antheia

• Antheia on Wikipedia, Google News & Yahoo Finance
• Antheia on LinkedIn, X (Twitter) & YouTube